Combination therapy includes cisplatin. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy3

Cell Line, Tumor Tumor Cells, Cultured Kidney

Organisms5

Mice, Nude Plasmodium falciparum Mice, Inbred BALB C Mice, SCID Hepacivirus

Diseases46

Lung Neoplasms Ovarian Neoplasms Head and Neck Neoplasms Vomiting Malaria, Falciparum Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Hepatitis C, Chronic Neutropenia Leukopenia Nausea Adenocarcinoma Malaria Neoplasms Stomach Neoplasms Disease Progression Neoplasm Recurrence, Local Testicular Neoplasms Carcinoma, Small Cell Neoplasm Metastasis Thrombocytopenia Disease Models, Animal Neoplasms, Germ Cell and Embryonal Hematologic Diseases Carcinoma Liver Neoplasms Parasitemia Germinoma Recurrence Esophageal Neoplasms Mesothelioma Breast Neoplasms Osteosarcoma Biliary Tract Neoplasms Pleural Neoplasms Urologic Neoplasms Hepatitis B, Chronic Melanoma Carcinoma, Hepatocellular Pancreatic Neoplasms Urinary Bladder Neoplasms Peritoneal Neoplasms Kidney Diseases Uterine Cervical Neoplasms Bone Neoplasms Arthritis, Rheumatoid

Chemicals and Drugs114

Cisplatin Antineoplastic Agents Artemisinins Drug Combinations Antimalarials Platinum Deoxycytidine Ribavirin Fluorenes Fluorouracil Paclitaxel Interferon-alpha Antiviral Agents Etoposide Vinblastine Ethanolamines Taxoids Oxonic Acid Amodiaquine Doxorubicin DNA Adducts Carboplatin Tegafur Camptothecin Polyethylene Glycols Methotrexate Antineoplastic Agents, Phytogenic Ifosfamide Mefloquine Sesquiterpenes Sulfadoxine Antimetabolites, Antineoplastic Pyrimethamine Antihypertensive Agents Chloroquine Sulfasalazine Cyclophosphamide Lamivudine Organophosphonates Antibodies, Monoclonal Bleomycin Recombinant Proteins Antibodies, Monoclonal, Humanized Guanine Mitomycin Hydrochlorothiazide Pyrazines Amlodipine Vindesine Tetrazoles Antirheumatic Agents Anti-Bacterial Agents Radiation-Sensitizing Agents Epirubicin Boronic Acids Antineoplastic Agents, Alkylating Adenine Quinolines Angiogenesis Inhibitors Angiotensin-Converting Enzyme Inhibitors Echinocandins Angiotensin II Type 1 Receptor Blockers Vincristine Tumor Suppressor Protein p53 Didanosine Antibiotics, Antineoplastic Antifungal Agents Anti-HIV Agents Dacarbazine Azetidines Indoles Triazoles Quinazolines Nifurtimox Reverse Transcriptase Inhibitors Amphotericin B Antiemetics Pyrimidines Piperazines Phenylurea Compounds Benzimidazoles Zidovudine Niacinamide Fenofibrate Carmustine Proto-Oncogene Proteins c-bcl-2 Sulfonamides Hydroxychloroquine Benzenesulfonates Mitolactol Ondansetron Bronchodilator Agents Pyridines Amifostine Enzyme Inhibitors Dexamethasone Protein Kinase Inhibitors Adrenal Cortex Hormones Prednisolone Hypoglycemic Agents Leucovorin Immunosuppressive Agents Pyrroles Albuterol Platinum Compounds RNA, Small Interfering Granulocyte Colony-Stimulating Factor Metformin Immunologic Factors Diuretics Aminoglycosides Simvastatin Sirolimus Caspase 3

Analytical, Diagnostic and Therapeutic Techniques and Equipment51

Drug Therapy, Combination Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Drug Administration Schedule Combined Modality Therapy Survival Analysis Drug Screening Assays, Antitumor Xenograft Model Antitumor Assays Infusions, Intravenous Disease-Free Survival Survival Rate Administration, Oral Neoplasm Staging Clinical Trials as Topic Drug Evaluation Double-Blind Method Retrospective Studies Inhibitory Concentration 50 Follow-Up Studies Maximum Tolerated Dose Remission Induction Prospective Studies Chemotherapy, Adjuvant Randomized Controlled Trials as Topic Neoplasm Transplantation Treatment Failure Disease Models, Animal Salvage Therapy Tumor Burden Drug Evaluation, Preclinical Kaplan-Meier Estimate Blotting, Western Neoadjuvant Therapy Infusions, Intra-Arterial Area Under Curve Prognosis Feasibility Studies Injections, Intravenous Parasitic Sensitivity Tests Hyperthermia, Induced Transplantation, Heterologous Pilot Projects Radiotherapy Dosage Administration, Inhalation Flow Cytometry Induction Chemotherapy Random Allocation Clinical Trials, Phase II as Topic Viral Load Radiotherapy Immunotherapy

Phenomena and Processes22

Drug Synergism Drug Resistance, Neoplasm Dose-Response Relationship, Drug Drug Resistance Apoptosis DNA Adducts Time Factors Cell Survival Drug Interactions Cell Proliferation DNA Damage Inhibitory Concentration 50 Maximum Tolerated Dose Drug Resistance, Multiple DNA Repair Gene Expression Regulation, Neoplastic Signal Transduction Area Under Curve Cell Cycle Viral Load Mutation Drug Resistance, Viral

Technology, Industry, Agriculture1

Polyethylene Glycols

Information Science1

Health Care17

Treatment Outcome Survival Analysis Disease-Free Survival Survival Rate Clinical Trials as Topic Double-Blind Method Retrospective Studies Follow-Up Studies Prospective Studies Randomized Controlled Trials as Topic Treatment Failure Kaplan-Meier Estimate Area Under Curve Feasibility Studies Pilot Projects Random Allocation Clinical Trials, Phase II as Topic

Geographicals3

Tanzania Cambodia Senegal

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Technology, Industry, Agriculture Information Science Health Care Geographicals

Cisplatin Drug Therapy, Combination Antineoplastic Combined Chemotherapy Protocols Antineoplastic Agents Artemisinins Treatment Outcome Drug Combinations Drug Synergism Drug Administration Schedule Combined Modality Therapy Antimalarials Platinum Drug Resistance, Neoplasm Deoxycytidine Cell Line, Tumor Ribavirin Fluorenes Fluorouracil Lung Neoplasms Paclitaxel Ovarian Neoplasms Interferon-alpha Dose-Response Relationship, Drug Antiviral Agents Etoposide Drug Resistance Apoptosis Vinblastine Ethanolamines Taxoids Survival Analysis Oxonic Acid Amodiaquine Doxorubicin Drug Screening Assays, Antitumor Xenograft Model Antitumor Assays DNA Adducts Infusions, Intravenous Carboplatin Head and Neck Neoplasms Vomiting Malaria, Falciparum Tegafur Mice, Nude Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Disease-Free Survival Camptothecin Hepatitis C, Chronic Survival Rate Polyethylene Glycols Methotrexate Time Factors Tumor Cells, Cultured Antineoplastic Agents, Phytogenic Neutropenia Ifosfamide Leukopenia Mefloquine Cell Survival Sesquiterpenes Drug Interactions Nausea Sulfadoxine Antimetabolites, Antineoplastic Adenocarcinoma Pyrimethamine Malaria Neoplasms Antihypertensive Agents Administration, Oral Chloroquine Sulfasalazine Neoplasm Staging Cyclophosphamide Clinical Trials as Topic Plasmodium falciparum Lamivudine Organophosphonates Stomach Neoplasms Antibodies, Monoclonal Bleomycin Cell Proliferation Disease Progression Recombinant Proteins Drug Evaluation DNA Damage Antibodies, Monoclonal, Humanized Double-Blind Method Neoplasm Recurrence, Local Testicular Neoplasms Retrospective Studies Guanine Mitomycin Carcinoma, Small Cell Inhibitory Concentration 50 Hydrochlorothiazide Pyrazines Follow-Up Studies Amlodipine

No FAQ available that match "combination therapy includes cisplatin"